Jazz Pharmaceuticals Plc (JAZZ)
243.64
-0.07
(-0.03%)
USD |
NASDAQ |
Sep 02, 10:20
Jazz Pharmaceuticals Net Income (TTM) : 940.76M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 940.76M |
| March 31, 2026 | 29.49M |
| December 31, 2025 | -356.15M |
| September 30, 2025 | -368.48M |
| June 30, 2025 | -404.84M |
| March 31, 2025 | 482.20M |
| December 31, 2024 | 560.12M |
| September 30, 2024 | 463.16M |
| June 30, 2024 | 394.92M |
| March 31, 2024 | 330.79M |
| December 31, 2023 | 414.83M |
| September 30, 2023 | 79.95M |
| June 30, 2023 | -86.51M |
| March 31, 2023 | -156.29M |
| December 31, 2022 | -224.06M |
| September 30, 2022 | -18.69M |
| June 30, 2022 | -51.87M |
| March 31, 2022 | -449.85M |
| December 31, 2021 | -329.67M |
| September 30, 2021 | -160.90M |
| June 30, 2021 | 40.16M |
| March 31, 2021 | 518.28M |
| December 31, 2020 | 238.62M |
| September 30, 2020 | 179.19M |
| June 30, 2020 | 133.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 280.33M |
| December 31, 2019 | 523.37M |
| September 30, 2019 | 608.84M |
| June 30, 2019 | 655.88M |
| March 31, 2019 | 486.31M |
| December 31, 2018 | 447.10M |
| September 30, 2018 | 519.84M |
| June 30, 2018 | 434.04M |
| March 31, 2018 | 447.33M |
| December 31, 2017 | 487.85M |
| September 30, 2017 | 372.33M |
| June 30, 2017 | 398.63M |
| March 31, 2017 | 407.53M |
| December 31, 2016 | 396.83M |
| September 30, 2016 | 362.90M |
| June 30, 2016 | 361.04M |
| March 31, 2016 | 334.65M |
| December 31, 2015 | 329.53M |
| September 30, 2015 | 328.38M |
| June 30, 2015 | 266.19M |
| March 31, 2015 | 221.66M |
| December 31, 2014 | 57.33M |
| September 30, 2014 | 31.01M |
| June 30, 2014 | 80.65M |
| March 31, 2014 | 79.25M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | -0.278M |
| Perrigo Co. Plc | -1.703B |
| GH Research Plc | -62.27M |
| Cosmo NV | -7.221M |
| Axsome Therapeutics, Inc. | -191.64M |